Stay updated with breaking news from Nasdaq Clbt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have earned an average rating of “Buy” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have covered the stock in […]
Cellebrite DI (NASDAQ:CLBT – Free Report) had its target price upped by Craig Hallum from $14.00 to $16.00 in a report released on Monday, Benzinga reports. The firm currently has a buy rating on the stock. Several other research analysts have also recently commented on CLBT. Needham & Company LLC upped their target price on […]
Cellebrite DI (NASDAQ:CLBT – Get Free Report) had its price objective boosted by research analysts at Craig Hallum from $14.00 to $16.00 in a research note issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. Craig Hallum’s price target indicates a potential upside of 45.19% from the stock’s previous […]
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) traded down 4.6% during trading on Wednesday . The stock traded as low as $11.29 and last traded at $11.32. 242,236 shares were traded during trading, a decline of 74% from the average session volume of 936,235 shares. The stock had previously closed at $11.87. […]
ARK Investment Management LLC trimmed its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 11.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 260,711 shares of the company’s stock after selling 33,020 shares during the period. ARK Investment Management LLC owned […]